Goodrx Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $6.015
- Today's High:
- $6.3
- Open Price:
- $6.13
- 52W Low:
- $3.82
- 52W High:
- $9.37
- Prev. Close:
- $6.18
- Volume:
- 941938
Company Statistics
- Market Cap.:
- $2.61 billion
- Book Value:
- 2.257
- Revenue TTM:
- $745.09 million
- Operating Margin TTM:
- 7.17%
- Gross Profit TTM:
- $701.48 million
- Profit Margin:
- 1.58%
- Return on Assets TTM:
- 2.03%
- Return on Equity TTM:
- 1.38%
Company Profile
Goodrx Holdings Inc had its IPO on 2020-09-23 under the ticker symbol GDRX.
The company operates in the Healthcare sector and Health Information Services industry. Goodrx Holdings Inc has a staff strength of 952 employees.
Stock update
Shares of Goodrx Holdings Inc opened at $6.13 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $6.02 - $6.3, and closed at $6.06.
This is a -1.94% slip from the previous day's closing price.
A total volume of 941,938 shares were traded at the close of the day’s session.
In the last one week, shares of Goodrx Holdings Inc have slipped by -7.48%.
Goodrx Holdings Inc's Key Ratios
Goodrx Holdings Inc has a market cap of $2.61 billion, indicating a price to book ratio of 2.8191 and a price to sales ratio of 2.5891.
In the last 12-months Goodrx Holdings Inc’s revenue was $745.09 million with a gross profit of $701.48 million and an EBITDA of $87.51 million. The EBITDA ratio measures Goodrx Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Goodrx Holdings Inc’s operating margin was 7.17% while its return on assets stood at 2.03% with a return of equity of 1.38%.
In Q2, Goodrx Holdings Inc’s quarterly earnings growth was a positive 663.5% while revenue growth was a negative 1.1%.
Goodrx Holdings Inc’s PE and PEG Ratio
- Forward PE
- 21.5983
- Trailing PE
- 327.5
- PEG
Its diluted EPS in the last 12-months stands at $0.02 per share while it has a forward price to earnings multiple of 21.5983 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Goodrx Holdings Inc’s profitability.
Goodrx Holdings Inc stock is trading at a EV to sales ratio of 2.7552 and a EV to EBITDA ratio of 33.7821. Its price to sales ratio in the trailing 12-months stood at 2.5891.
Goodrx Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $1.69 billion
- Total Liabilities
- $82.55 million
- Operating Cash Flow
- $-14959000.00
- Capital Expenditure
- $14.96 million
- Dividend Payout Ratio
- 0%
Goodrx Holdings Inc ended 2024 with $1.69 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.69 billion while shareholder equity stood at $895.37 million.
Goodrx Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $82.55 million in other current liabilities, 40000.00 in common stock, $-1393039000.00 in retained earnings and $412.12 million in goodwill. Its cash balance stood at $761.99 million and cash and short-term investments were $761.99 million. The company’s total short-term debt was $9,757,000 while long-term debt stood at $649.75 million.
Goodrx Holdings Inc’s total current assets stands at $919.25 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $123.38 million compared to accounts payable of $6.80 million and inventory worth $0.
In 2024, Goodrx Holdings Inc's operating cash flow was $-14959000.00 while its capital expenditure stood at $14.96 million.
Comparatively, Goodrx Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $6.06
- 52-Week High
- $9.37
- 52-Week Low
- $3.82
- Analyst Target Price
- $8.39
Goodrx Holdings Inc stock is currently trading at $6.06 per share. It touched a 52-week high of $9.37 and a 52-week low of $9.37. Analysts tracking the stock have a 12-month average target price of $8.39.
Its 50-day moving average was $6.91 and 200-day moving average was $5.76 The short ratio stood at 1.45 indicating a short percent outstanding of 0%.
Around 284.8% of the company’s stock are held by insiders while 6314.3% are held by institutions.
Frequently Asked Questions About Goodrx Holdings Inc
Similar Industry Stocks (Health Information Services)
Most Active
Top Gainers
Top Losers
About
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is headquartered in Santa Monica, California.